Helen Chernovets-Vergilis, NP
NPI 1962823732 · Family Nurse Practitioner · Brooklyn, NY
Enrolled with Medicare as Practitioner - Nurse Practitioner · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1962823732
- Entity type
- Individual
- Primary specialty
- Family Nurse PractitionerPhysician Assistants & Advanced Practice Nursing Providers
- Credential
- NP
- Sex
- Female
- Sole proprietor
- Yes
- License
- 338700 (NY)
Specialties & taxonomies
Physician Assistants & Advanced Practice Nursing Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
12 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
2 documented practice locations
- Medicare service volume (vs. specialty peers)25% of score
2,260 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 937 | $7 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 355 | $88 |
| Destruction of Skin Growth, 1-14 Growths17110 | 217 | $111 |
| Biopsy of Related Skin Growth, First Growth11102 | 171 | $72 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 145 | $44 |
| Destruction of Precancer Skin Growth, 15 Or More Growths17004 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 40 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Ketoconazole | 370 | 156 |
| Mupirocin | 253 | 213 |
| Metronidazole | 126 | 80 |
| Clobetasol Propionate | 125 | 66 |
| Triamcinolone Acetonide | 125 | 86 |
| Clotrimazole/Betamethasone Dipbrand: Clotrimazole-Betamethasone | 103 | 66 |
| Silver Sulfadiazine | 102 | 76 |
| Gentamicin Sulfate |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$695 across 10 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Additional practice locations (1)
- 3537 Forest Hill Blvd Ste BWest Palm Beach, FL 33406-5867Phone: (561) 892-6002
Registry dates
- Enumerated
- 2013-12-22
- Last updated
- 2024-02-21
- Certified
- 2024-02-21
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.